Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease (PIR-001/K)

This study has been completed.
Information provided by:
Desitin Arzneimittel GmbH Identifier:
First received: July 28, 2008
Last updated: March 30, 2010
Last verified: July 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2008
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)